(RGLD) Royal Gold - Overview
Stock: Gold, Silver, Copper, Nickel, Zinc
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.97% |
| Yield on Cost 5y | 1.77% |
| Yield CAGR 5y | 10.67% |
| Payout Consistency | 96.2% |
| Payout Ratio | 26.0% |
| Risk 5d forecast | |
|---|---|
| Volatility | 41.3% |
| Relative Tail Risk | -0.43% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.81 |
| Alpha | 77.38 |
| Character TTM | |
|---|---|
| Beta | 0.327 |
| Beta Downside | 0.062 |
| Drawdowns 3y | |
|---|---|
| Max DD | 28.86% |
| CAGR/Max DD | 1.07 |
Description: RGLD Royal Gold January 04, 2026
Royal Gold Inc. (NASDAQ:RGLD) is a royalty and streaming company that acquires and manages interests in precious-metal production. It trades cash or equity for a fixed-percentage stream of future metal output-primarily gold, silver, copper, nickel, zinc, lead, and molybdenum-from operating mines, development projects, and exploration ventures across North America, South America, Australia, Africa, and the Dominican Republic.
As of the most recent quarter, Royal Gold reported a market-capitalization of roughly $7 billion, a dividend yield near 3.5 %, and a cash-flow-coverage ratio of 1.9×, indicating that operating cash from its royalty portfolio comfortably exceeds its dividend obligations. The company’s “Royalty Income” segment contributed about $550 million in the last twelve months, with gold accounting for roughly 70 % of total metal revenue.
The firm’s performance is tightly linked to macro-level drivers: (1) spot gold prices, which have hovered above $1,900 per ounce in 2024, (2) global inflation trends that sustain demand for safe-haven assets, and (3) the supply-side health of mining projects, especially in jurisdictions where Royal Gold holds long-term contracts. A rise in real interest rates would typically pressure gold prices, while a slowdown in mining capital expenditures could reduce the pipeline of new royalty opportunities.
For a deeper, data-driven look at Royal Gold’s valuation metrics and scenario analysis, you might find the free research tools on ValueRay useful.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 480.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.14 > 0.02 and ΔFCF/TA -26.74 > 1.0 |
| NWC/Revenue: 21.94% < 20% (prev 17.41%; Δ 4.53% < -1%) |
| CFO/TA 0.14 > 3% & CFO 604.2m > Net Income 480.1m |
| Net Debt (597.3m) to EBITDA (702.6m): 0.85 < 3 |
| Current Ratio: 2.89 > 1.5 & < 3 |
| Outstanding Shares: last quarter (65.8m) vs 12m ago 0.06% < -2% |
| Gross Margin: 75.59% > 18% (prev 0.79%; Δ 7479 % > 0.5%) |
| Asset Turnover: 22.04% > 50% (prev 20.14%; Δ 1.90% > 0%) |
| Interest Coverage Ratio: 44.90 > 6 (EBITDA TTM 702.6m / Interest Expense TTM 12.7m) |
Altman Z'' 3.30
| A: 0.04 (Total Current Assets 287.4m - Total Current Liabilities 99.5m) / Total Assets 4.47b |
| B: 0.26 (Retained Earnings 1.17b / Total Assets 4.47b) |
| C: 0.15 (EBIT TTM 571.8m / Avg Total Assets 3.88b) |
| D: 1.12 (Book Value of Equity 1.17b / Total Liabilities 1.05b) |
| Altman-Z'' Score: 3.30 = A |
Beneish M -2.83
| DSRI: 1.17 (Receivables 90.5m/60.3m, Revenue 855.9m/665.0m) |
| GMI: 1.05 (GM 75.59% / 79.49%) |
| AQI: 0.71 (AQ_t 0.02 / AQ_t-1 0.02) |
| SGI: 1.29 (Revenue 855.9m / 665.0m) |
| TATA: -0.03 (NI 480.1m - CFO 604.2m) / TA 4.47b) |
| Beneish M-Score: -2.83 (Cap -4..+1) = A |
What is the price of RGLD shares?
Over the past week, the price has changed by +0.93%, over one month by +8.74%, over three months by +56.97% and over the past year by +85.12%.
Is RGLD a buy, sell or hold?
- StrongBuy: 4
- Buy: 4
- Hold: 2
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the RGLD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 305.1 | 14.8% |
| Analysts Target Price | 305.1 | 14.8% |
| ValueRay Target Price | 357.2 | 34.4% |
RGLD Fundamental Data Overview January 31, 2026
P/E Forward = 20.7469
P/S = 34.445
P/B = 7.234
P/EG = 1.41
Revenue TTM = 855.9m USD
EBIT TTM = 571.8m USD
EBITDA TTM = 702.6m USD
Long Term Debt = 770.2m USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 770.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 597.3m USD (from netDebt column, last quarter)
Enterprise Value = 22.82b USD (22.22b + Debt 770.2m - CCE 172.8m)
Interest Coverage Ratio = 44.90 (Ebit TTM 571.8m / Interest Expense TTM 12.7m)
EV/FCF = -37.58x (Enterprise Value 22.82b / FCF TTM -607.2m)
FCF Yield = -2.66% (FCF TTM -607.2m / Enterprise Value 22.82b)
FCF Margin = -70.94% (FCF TTM -607.2m / Revenue TTM 855.9m)
Net Margin = 56.09% (Net Income TTM 480.1m / Revenue TTM 855.9m)
Gross Margin = 75.59% ((Revenue TTM 855.9m - Cost of Revenue TTM 209.0m) / Revenue TTM)
Gross Margin QoQ = 73.53% (prev 72.56%)
Tobins Q-Ratio = 5.11 (Enterprise Value 22.82b / Total Assets 4.47b)
Interest Expense / Debt = 1.12% (Interest Expense 8.62m / Debt 770.2m)
Taxrate = 17.88% (28.7m / 160.5m)
NOPAT = 469.6m (EBIT 571.8m * (1 - 17.88%))
Current Ratio = 2.89 (Total Current Assets 287.4m / Total Current Liabilities 99.5m)
Debt / Equity = 0.23 (Debt 770.2m / totalStockholderEquity, last quarter 3.41b)
Debt / EBITDA = 0.85 (Net Debt 597.3m / EBITDA 702.6m)
Debt / FCF = -0.98 (negative FCF - burning cash) (Net Debt 597.3m / FCF TTM -607.2m)
Total Stockholder Equity = 3.26b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.36% (Net Income 480.1m / Total Assets 4.47b)
RoE = 14.73% (Net Income TTM 480.1m / Total Stockholder Equity 3.26b)
RoCE = 14.19% (EBIT 571.8m / Capital Employed (Equity 3.26b + L.T.Debt 770.2m))
RoIC = 13.60% (NOPAT 469.6m / Invested Capital 3.45b)
WACC = 6.91% (E(22.22b)/V(22.99b) * Re(7.12%) + D(770.2m)/V(22.99b) * Rd(1.12%) * (1-Tc(0.18)))
Discount Rate = 7.12% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 0.08%
Fair Price DCF = unknown (Cash Flow -607.2m)
EPS Correlation: 26.73 | EPS CAGR: -47.70% | SUE: -4.0 | # QB: 0
Revenue Correlation: 72.36 | Revenue CAGR: 11.75% | SUE: -1.13 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.88 | Chg30d=+0.515 | Revisions Net=+0 | Analysts=2
EPS next Year (2026-12-31): EPS=12.14 | Chg30d=+0.752 | Revisions Net=+1 | Growth EPS=+50.6% | Growth Revenue=+79.0%